Evidence map›Paper›PMID 40166967›Full record

ReviewWater environment research : a research publication of the Water Environment Federation2025

An update on hybrid membrane aerated biofilm reactor technology.

Huanqi He, Avery Lachlann Carlson, Brett Wagner, Cheng Yang, Yi Cao, Mohammed Dilshaad Uzair, Glen T Daigger

Abstract readReview
In one paragraph

Review in Water environment research : a research publication of the Water Environment Federation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. An update on hybrid membrane aerated biofilm reactor technology.Water environment research : a research publication of the Water Environment Federation · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Huanqi HeGeorgia Tech, Atlanta, Georgia, USA.
Avery Lachlann CarlsonJacobs Engineering Group Inc., Dallas, Texas, USA.
Brett WagnerAECOM, Dallas, Texas, USA.
Cheng YangJacobs Engineering Group Inc., Dallas, Texas, USA.
Yi CaoUniversity of Michigan, Ann Arbor, Michigan, USA.
Mohammed Dilshaad UzairUniversity of Michigan, Ann Arbor, Michigan, USA.
Glen T DaiggerUniversity of Michigan, Ann Arbor, Michigan, USA.ORCID https://orcid.org/0000-0003-3857-8345

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The hybrid membrane aerated biofilm reactor (MABR) process combines the advantages of the counter-diffusional biofilm and bubbleless aeration of the MABR with the good bioflocculation and carbon processing capabilities of suspended growth processes. These features result in a process with reduced physical footprint, excellent biological nutrient removal capabilities, potentially reduced greenhouse gas (GHG) emissions, and significantly reduced energy requirements that can be easily retrofitted into existing suspended growth processes. Commercially introduced in the mid-2010s, the demonstrated advantages of the hybrid MABR process are resulting in rapid full-scale adoption. Meanwhile, researchers are advancing knowledge on the hybrid MABR process and revealing potential opportunities for improved performance. This paper summarizes recent findings and identifies areas that can be further developed to advance hybrid MABR process evaluation and development. PRACTITIONER POINTS: Rapid application of the hybrid MABR process is leading to significant new developments that can enhance performance. Sizing MABR for nearly complete nitrification allows significant downsizing of the bioreactor, coupled with excellent nitrogen removal and energy savings. Online exhaust gas % O

Indexed as

BiofilmsBioreactorsMembranes, ArtificialWaste Disposal, FluidMembranes, Artificialbiological nutrient removalMABRresource recoverysuspended growth

Identifiers

PMID40166967
PMCPMC11959682

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.